Skip to content

The effectiveness of Plantago major in the treatment of mucositis

Evaluating the effectiveness of Plantago major extract in the treatment of oral mucositis in patients undergoing stem cell transplantation: a randomized double-blind controlled clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150721023282N28
Enrollment
28
Registered
2024-12-07
Start date
2024-12-21
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral mucositis. Oral mucositis (ulcerative)

Interventions

Intervention 1: Intervention group: Barhang mouthwash solution 10%, 4 times a day, each time in the amount of 8 ml and two minutes for 10 days. Intervention 2: Control group: Combined mouthwash (conta

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age of 18 years or more Hospitalization, hematopoietic cell transplant department Suffering from grade 1, 2 or 3 mucositis according to the WHO scale following chemotherapy preparation for hematopoietic cell transplantation. Informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Radiotherapy Use of other mouthwashes Use of artificial saliva products Taking antidepressants Taking systemic antihistamines Alcohol consumption Having an underlying rheumatological disease Having oral candidiasis Oral herpes

Design outcomes

Primary

MeasureTime frame
Change in the average intensity of mucositis and pain intensity. Timepoint: Pain intensity on the fourth, seventh and end days of the intervention, as well as the number of patients with mild, moderate and severe mucositis. Method of measurement: The severity of mucositis is based on the WHO scale and the pain intensity evaluation criterion is the VAS (visual analog scale).

Secondary

MeasureTime frame
Number of possible cases of complete recovery (reaching zero grade) during the intervention. Timepoint: End of ontervention (10th day). Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsoltani@pharm.mui.ac.ir

Esfahan University of Medical Sciences

soltani@pharm.mui.ac.ir+98 31 3792 7067

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026